泛生子基因科技有限公司

公司简介

泛生子（纳斯达克代码：GTH）是全球前沿的癌症精准医疗公司，专注癌症基因组学的研究和应用，提供癌症早期筛查、用药指导、预后及监测、肿瘤新药研发服务等覆盖癌症全周期的产品与服务，致力于将创新基因组学技术，应用于与癌症相关的诊断、治疗，最终战胜癌症。

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a world-leading precision oncology platform company that specializes in research and application of cancer genomics, providing early screening, medication guidance, prognosis and monitoring, and new cancer drug development services that cover the entire spectrum of cancer management. The company is committed to applying innovative genomics technology to cancer-related diagnosis and treatment, and ultimately defeating cancer.